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Abstract
Background: IPTi delivered through EPI has been shown to reduce the incidence of clinical
malaria by 20–59%. However, new health interventions can only be effective if they are also socially
and culturally acceptable. It is also crucial to ensure that attitudes to IPTi do not negatively influence
attitudes to and uptake of immunization, or that people do not misunderstand IPTi as immunization
against malaria and neglect other preventive measures or delay treatment seeking.
Methods: These issues were studied in five African countries in the context of clinical trials and
implementation studies of IPTi. Mixed methods were used, including structured questionnaires
(1,296), semi-structured interviews (168), in-depth interviews (748) and focus group discussions
(95) with mothers, fathers, health workers, community members, opinion leaders, and traditional
healers. Participant observation was also carried out in the clinics.
Results: IPTi was widely acceptable because it resonated with existing traditional preventive
practices and a general concern about infant health and good motherhood. It also fit neatly within
already widely accepted routine vaccination. Acceptance and adherence were further facilitated by
the hierarchical relationship between health staff and mothers and by the fact that clinic attendance
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had a social function for women beyond acquiring health care. Type of drug and regimen were
important, with newer drugs being seen as more effective, but potentially also more dangerous.
Single dose infant formulations delivered in the clinic seem to be the most likely to be both
acceptable and adhered to. There was little evidence that IPTi per se had a negative impact on
attitudes to EPI or that it had any affect on EPI adherence. There was also little evidence of IPTi
having a negative impact on health seeking for infants with febrile illness or existing preventive
practices.
Conclusion: IPTi is generally acceptable across a wide range of settings in Africa and involving
different drugs and regimens, though there is a strong preference for a single dose infant
formulation. IPTi does not appear to have any negative effect on attitudes to EPI, and it is not
interpreted as immunization against malaria.
Background
Intermittent preventive treatment (IPT) of malaria
involves the administration of treatment doses of an anti-
malarial drug at predetermined intervals, regardless of
parasitaemia or symptoms. Compared to continuous che-
moprophylaxis, IPT reduces the number of times an indi-
vidual has to be given the anti-malarial, and can avoid the
problem of delivery if it is given at routine health visits:
IPT during pregnancy (IPTp) is linked to ongoing routine
antenatal care and IPT for infants (IPTi) is delivered
through the Expanded Programme of Immunization
(EPI) [1].
Various studies in Africa have shown IPTi with sulphadox-
ine-pyrimethamine (SP) given at the time of routine vac-
cinations in the first year of life reduces the incidence of
clinical malaria by between 20% and 59% [2-7], and by
30% across the six sites [8]. However, new preventive
health interventions such as IPTi can only be considered
completely effective if they are also socially and culturally
acceptable, and are widely adhered to in the longer-term.
It is also crucial to ensure that new additions to EPI do not
negatively influence people's attitudes to and uptake of
immunization, or that people do not misunderstand IPTi
as immunization against malaria and as a result neglect
other preventive measures or delay treatment seeking. The
importance of acceptability was emphasized in a recent
report by the Institute of Medicine [9].
To date the results of two studies that have examined the
reception of IPTi, both under the auspices of the IPTi Con-
sortium [10], have been published [11,12]. Because these
studies were carried out in the same south-east African
coastal region (in Mozambique and southern Tanzania),
and both involved only SP, they do not, by themselves,
allow the sort of generalization necessary to make wider
policy recommendations relating to the acceptability of
IPTi across Africa, or for the development of general con-
tinent-wide implementation guidelines. They also do not
provide any data on the reception of drugs other than SP.
There was therefore a need for further research across a
range of geographical, political and cultural settings, and
transmission areas, and involving a variety of drugs and
regimens, so that conclusions applicable to a wide range
of IPTi implementation settings throughout Africa could
be drawn. Consequently, the IPTi Consortium Acceptabil-
ity Working Group (AWG) developed a programme of
anthropological research that expanded the results from
the Mozambique and southern Tanzania studies by using
the same approach and methods to examine the socio-cul-
tural issues related to the reception of IPTi in five new set-
tings across Africa. These anthropological studies were all
linked to efficacy trials of IPTi (in Gabon, Kenya and
north-eastern Tanzania) or implementation studies (in
Malawi and Ghana) and involved very different settings
and different drugs and regimens (Table 1). The earlier
two studies in Mozambique and southern Tanzania had
been linked to an efficacy trial [4] and a community effec-
tiveness study [13] respectively.
Although this paper focuses on the results of the newer
studies, reference will be made to the two older projects as
many of the findings are remarkably similar and because
the objectives, approach and methods have been so simi-
lar as to justify considering the data from all the projects
as a single set. However, differences in the design of ques-
tionnaires and topic guides between the newer and the
older studies have made it impractical to combine the
data into a single database. This programme of research is
the most comprehensive study of the acceptability and
reception of a public health intervention that has ever
been carried out.
The scientific objectives of the programme were:
1. To describe knowledge, perceptions, experiences
and responses relating to IPTi and EPI of trial partici-
pants, community members, and local health care
providers across a range of geographical and cultural
settings and transmission areas, and involving a range
of anti-malarial drugs and regimens.Malaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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2. To identify and understand the mutual interactions
between perceptions of, attitudes to and experiences
with EPI and IPTi.
3. To identify and understand local barriers to the
acceptance of and long-term adherence to IPTi.
4. To identify wider socio-cultural, national and
regional factors that affect, or may affect, the imple-
mentation or acceptability of IPTi.
Methods
Settings
The data on which this paper is based come mainly from
Kenya, north-eastern Tanzania, Gabon, Ghana and
Malawi; countries in which some of the more recent IPTi
clinical trials and implementation studies have been car-
ried out. The study in Kenya took place in western Kenya
(Asembo, Rarieda district). In north-eastern Tanzania the
study was carried out in two sites: a moderate transmis-
sion site (Korogwe District, Tanga Region) and a neigh-
bouring low transmission site (Same District, Kilimanjaro
Region). In Gabon the study was carried out in the Albert
Schweitzer Hospital in Lambaréné town in the Moyen
Ogoouée province. The implementation study in north-
ern Ghana was undertaken in the Upper East region, in
Bawku, Kassena-Nankana, Bolgatanga and Builsa districts.
In Malawi, IPTi was delivered in two districts, Lilongwe
and Salima, in the central region of the country. Although
IPTi was delivered in all static and outreach clinics
throughout the two districts, the acceptability study was
conducted in two clinics in Lilongwe and one clinic in
Salima.
The choice of study sites was determined by a combina-
tion of the scientific need to have as broad and represent-
ative a range of settings, drugs and regimens as possible
and the pragmatic limitations imposed by the location of
other IPTi Consortium studies, the willingness of local
research institutions to host the anthropological studies
and the funds available. The original intention had been
to carry out anthropological studies in parallel to the clin-
ical trials in Gabon, Kenya and Tanzania and the imple-
mentation of IPTi in Ghana and Malawi. However, the
timing of the various Consortium trials was not entirely
synchronized and the idea of conducting a cross-site
Table 1: AWG study sites and related IPTi Consortium projects
Site Study design Drug and regimens
Kenya, Asembo (Rarieda district) Randomized controlled trial SP + 3 days of artesunate (AS) 3 days of amodiaquine (AQ)+AS, 
3 days of chlorproguanil-dapsone (CD), or 3 days of placebo; all 
arms with daily iron supplementation from 2 to 6.5 months of 
age
Day 1 dose of study drugs provided at 10, and 14 weeks and 9 
months EPI visit. On day 2 and 3 the drug was administered in 
the home under supervision by compliance monitors. Follow-up 
to 24 months
North-eastern Tanzania, Korogwe and Same 
districts
SP
Mefloquine (MQ)
3 days of CD, or 3 days of placebo.
The drugs were administered at 3, 4 and 9 months, with the first 
dose of the drug administered under supervision at the clinic 
and the 2nd and 3rd dose at home unsupervised. Follow-up until 
24 months.
Gabon, Lambaréné SP or placebo was administered at 3, 9, and 15 months, follow-
up until 30 months of age.
Ghana (Navrongo), Bawku, Kassena-Nankana, 
Bolgatanga and Builsa districts
Implementation study SP at the time of PENTA 2, PENTA 3 and measles vaccinations 
administered at 2 months, 3 months and 9 months respectively.
Malawi, Lilongwe and Salima SP was administered at the time of DPT2 (10 weeks), DPT3 (14 
weeks) and measles vaccinations (9 months).
SP – Sulphadoxine-Pyrimethamine
AS – Artesunate
AQ – Amodiaquine
CD – Chlorproguanil-Dapsone
MQ – Mefloquine
DPT – Diphtheria, Pertussis, Tetanus
PENTA – DPT, HepB, HibMalaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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anthropological study only developed after some of the
trials were in a relatively advanced stage. As a result the
Gabon trial had ended and the trials in Kenya and Tanza-
nia had completed recruitment and were in the follow-up
phase by the time the AWG anthropological study was
funded and ready to start. It was therefore decided to carry
out a smaller retrospective study in Gabon. In Gabon,
Kenya and Tanzania it was not possible for the anthropol-
ogy team to directly observe the implementation of IPTi.
In Ghana and Malawi direct observation was possible as
IPTi was being implemented concurrently with the
anthropological studies.
Methodologies
The general approach was anthropological, but the design
involved the use of integrated mixed-methods.
• Anthropology and grounded theory
Starting from the relatively broad objectives of the pro-
gramme (see above) and questions and topics developed
in the previous IPTi acceptability studies, this study used
an iterative, cumulative, process of data collection, ongo-
ing analysis and adjustment of instruments to gradually
narrow down to the details of very specific topics. This
process resulted in the continual development and intro-
duction of new qualitative topic-specific question guides
and questionnaires throughout the programme. New data
were continually compared to data already collected
through a process of triangulation. This process continued
until a point of saturation was reached i.e. when no more
new information emerged from the data, and no new
insights were generated and a conceptually dense account
of the topics of interest were developed, with all categories
accounted for, variations within them explained and rela-
tionships between them established and confirmed in a
range of settings [14,15].
• Integrated mixed methods
Data were collected using both quantitative and qualita-
tive methods. Based on a mixed-method model devel-
oped to study sexual behaviour change [16] and later
implemented in a large multi-centre HIV prevention trial
[17]. Qualitative and quantitative approaches were not
only used in parallel to collect data but also integrated
into the same instrument. For example, the structured
questionnaires and in-depth interview guides focused on
the same topics and the in-depth interview guides also
contained summary fields and multiple-choice answers
with tick-boxes that enabled some key responses from the
open interviews to be coded and quantified during the
interview. As a result, data from both instruments could
be included in the same quantitative database and the in-
depth interviews provided deeper insights and explana-
tions relating directly to the quantitative data.
Main methods (see Table 2 for additional details):
￿ Direct observation of practical situations relating to
IPTi or relevant to the wider context of IPTi implemen-
tation (for example, observations of the delivery of
routine vaccination and IPTi in clinics).
￿  Structured interviews (1,296) with mothers of
infants receiving IPTi or routine vaccination, hus-
bands/partners, IPTi trial staff, community members,
local opinion leaders, health care providers and tradi-
tional healers.
￿ Semi-structured interviews (168) with fathers.
￿ In-depth interviews (IDIs) (748) with a sub-sample
of the above.
￿ Focus group discussions (FGDs) (95) with moth-
ers, community members, health staff and local opin-
ion leaders
￿ Text analysis of relevant documents and messages
(media reports, government policy documents and
health education materials)
Initial sampling was based on convenience, e.g. mothers
who were willing to be interviewed were recruited
through study clinics. As the study developed theoretical
sampling was used: participants were recruited on the
basis of the research team's developing understanding of
the field and the questions that emerged from the ongoing
analysis of already collected data. The numbers of inter-
views, FGDs, etc were determined by the saturation dis-
cussed above. Data were collected using standardized
methods across all the sites except Gabon. The Gabon
study was much smaller than the others and consisted of
two fieldwork periods of two months and one month
respectively. Due to the difficulty in recruiting local social
scientists for such a short project, consultants were hired
to collect the data. In the other sites fieldwork lasted for 18
months and was carried out by a site-based team of three
to four interviewers, headed by a site principal investiga-
tor (PI) (who was also the local PI of the related Consor-
tium trial or intervention study) and a senior social
scientist.
Participants were selected as follows:
￿ Participant mothers were all selected through the
study clinics. In Kenya and Tanzania they were
selected during IPTi trial follow-up visits or, after fol-
low-up was completed, during routine clinic visits. In
Gabon children who participated in the IPTi trial and
their siblings continued to receive free medical treat-Malaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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ment after follow-up and mothers were recruited for
the acceptability interviews during such visits. In the
implementation sites in Ghana and Malawi women
were selected from among those attending the EPI
clinic. Although interviewers ensured that they
selected a representative range of participants with
regard to age, selection was also to a large extent by
convenience, because they had to fit the interviews
into the busy clinic routine and catch women in wait-
ing areas before of after they were attended to. Women
who had "more to say" were selected for follow-up
interviews.
￿ Drop-out mothers were identified from clinic data
and traced at home.
￿ Fathers were recruited through mothers who were
interviewed and who consented to their partners being
approached with a request for an interview.
￿ All health workers at the study clinics were inter-
viewed.
￿ Traditional healers were chosen from among those
in the vicinity of the clinic who were known to treat
infants.
￿ Opinion leaders were selected based on recommen-
dations from local community members and clinic
staff.
Table 2: Study populations and numbers of interviews and focus groups
Type of respondent Data collection toola Kenya Gabon Tanzania Ghana Malawi Total
Participant mothers IDI 75 63 47 57 242b
QNN 122 119 148 159 137 685
Mother drop outsc IDI 8 21 22 42 93
Fathers SSI 15 33 80 40 168
Health workers IDI 27 47 26 25 125
QNN 12 26 35 44 117
Health worker follow-up IDI 23 47 15 14 99
Volunteer health worker IDI NA NA 23 15 38
Opinion leaders IDI 7 26 27 20 80
Traditional healers IDI 2 23 31 15 71
Non-participant mothers IDI NA 38+26d NA NA NA 64
Informal conversations 76 76
Participant mothers FGD 0e 19 27 18 64
Community members FGD 11 10 10 10 31
Community members (non-participant mothers) QNN 263+231f 494
a IDI: in-depth interview; QNN: questionnaire; FGD: focus group discussion; SSI: semi-structured interview
b Not all respondents have been included in the data that were analysed quantitatively as data collection tools varied between Gabon and the other 
sites. Furthermore, some modifications of the data collection tools across the other sites ensured that not all interviews could be entered in the 
same database. Therefore, for example although 927 participant mothers were interviewed across the five sites, the total of participant mothers 
referred to in the quantitative data is lower (805). All data were included for qualitative analysis.
c Although aggregated as "drop outs" across the four sites, the exact definition is different in the implementation studies and the clinical trials.
d In Gabon, due to the retrospective nature of data collection carried out by a consultant, a sample of mothers from the local area were 
interviewed during two periods of fieldwork.
e In Kenya, participant mothers took part in FGDs organized with other non-participant mothers and hence have been classified as community 
members.
f Two questionnaire surveys were undertaken in Gabon: with mothers in local schools and mothers at the mother and child clinic.Malaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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The analysis of the qualitative data has been through a
Grounded Theory approach [14], with more abstract gen-
eralizations emerging from the data based on the coding
of emerging themes using Nvivo 2, a computer pro-
gramme which enables the management, coding and
analysis of large sets of qualitative data. Descriptive statis-
tics from the qualitative data were generated using SPSS
14.0. Data were compared across the sites to generate a
comparative picture of the reception of IPTi.
Ethics procedures
Overall ethics clearance for this study was obtained from
the Ethics Committee of the Comité Ético de Investi-
gación Clínica of the University of Barcelona. Separate
local ethical clearance was obtained at each site, and for
Kenya and Tanzania additional clearance was obtained
from the London School of Hygiene and Tropical Medi-
cine and the Centers for Disease Control and Prevention,
Atlanta. Informed consent was obtained from all study
participants in accordance with local ethics committee
regulations.
Results
Acceptability and adherence
A number of key factors have emerged from the data
across all the study sites that influence the acceptability of
IPTi in either positive or negative ways. These factors
relate to the local cultural and health-care context, the
clinic environment and the nature of the drugs and regi-
mens used for IPTi. There is a great deal of similarity
across the sites.
Local health culture and the routinization of EPI
In all the study communities there was a general and
widespread concern about infant health, and an underly-
ing assumption that one should do all that is possible to
ensure infant well-being. This is a strong motivation for
mothers to comply with prevention practices and pro-
grammes, either traditional or biomedical, whether they
fully understand them or not. Non-adherence to any
activity that is perceived as being beneficial to infant
health is likely to be seen as neglect, and so there is strong
social pressure to comply and be seen as a "good mother".
More than half of mothers in Tanzania, Kenya, Malawi
and Ghana (53% [427/805]) said that traditional prac-
tices for preventing illness or ensuring health and well-
being in infants were widely used. There was some varia-
tion across the sites (Kenya 22% [43/197], Tanzania 54%
[112/208], Ghana 62% [127/206], Malawi 75% [145/
194]). These practices varied from interventions aimed
directly at babies and infants (such as ritual or herbal
treatments carried out by traditional healers or the wear-
ing of amulets) to more indirect measures aimed at par-
ents (such as the observation of postpartum sexual
abstinence and seclusion by mothers). In Gabon, mothers
mentioned traditional immunization practices in 52 (of
64) open interviews. In these interviews 34 women said
they had used traditional "vaccination", mainly for their
children, but also for themselves. Such traditional prac-
tices were also commonly reported in the earlier studies
[11,12].
Interviewer: How does it work, what does the traditional
healer do?
Mother: Vaccination.
Interviewer: Are these vaccinations like scarification, what
does the traditional healer do?
Mother: In fact they vaccinate against certain spirits...it is
to prevent all contact with what the sorcerer could do and
to prevent the illnesses he could send, so that these don't
affect you.
(IDI, mother, Gabon)
This traditional prevention may involve rituals or herbal
treatment.
Most women (87% [700/805]) said that they used bed
nets for preventing malaria (Tanzania 98% (204/208),
Kenya 99% (195/197), Ghana 84% (173/206) and
Malawi 66% (128/194)). Usually nets were distributed
free at clinics to mothers who had just given birth or when
vaccinating their babies. In Kenya, nets were distributed to
participants at the time of enrolment. Across the sites one
quarter of mothers (24% 192/805) also said they used
other means of (perceived) malaria prevention, such as
clearing bushes around their compounds, clearing gutters
of standing water, or fumigating their houses using spray
or by burning leaves, seeds, or dung. This also varied
across the sites, from 50% in Ghana, where insecticide
sprays were popular, to 7% in Tanzania. These practices
were also frequently described in the FGDs.
Women were generally familiar with, and accepted, IPTp.
Women in some of the sites spoke about IPTp and IPTi as
a continuum, with IPTp providing protection against
malaria for both mother and child before birth and IPTi
providing protection for the child after birth. This was
reported less often than in the Mozambique and southern
Tanzania data [11,12], but was not mentioned at all in
Kenya.
EPI was generally well established at the study sites and
had largely become routinized. However, knowledge of
vaccination was often not detailed. Most mothers [87%
(702/805)] knew that vaccination prevents disease (thereMalaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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were minimal differences between the sites), but only 2%
(20/805) knew exactly which diseases were prevented
(10/20 were from Tanzania). Eleven percent of mothers
(88/805) mentioned that vaccination was "the law"
which they were obliged to follow (43/88 were from Tan-
zania, 27/88 from Kenya).
It is the law that you must take your child to the clinic.
(IDI, mother, Ghana)
Facilitator: Why do you think women come for vaccina-
tions?
All: It is a law.
Facilitator: A law from where?
Mother: A law from the government.
Facilitator: What do they do to you if you don't attend the
clinic for vaccination; do they send you to the prison?
Mother: They don't send you to the prison but it is just
important.
(FGD, mothers, Tanzania)
Most women were critical of other women who, they
claimed, neglected to have their children vaccinated due
to laziness or ignorance.
Although mothers sometimes reported side effects of vac-
cination, mainly fever (38% [304/805]) local swelling
(6% [47/805]) and the infant crying (6% [47/805]), they
generally did not consider these to be serious (there was
little difference in the profile of side effects reported across
the sites, except "crying" was more readily reported in
Malawi. There was however variation in the proportion of
mothers reporting side effects across the sites: Tanzania
24% [51/208]; Malawi 46% [92/194]; Kenya 48% [95/
197]; Ghana 58% [120/206]). Of the mothers who
reported side effects, 64% (228/357) said that they were
not serious. Some saw these mild side effects as evidence
that the vaccination "worked".
It is true actually even my youngest child got swelling, but I
have noticed that after vaccination the child must get fever.
When the child gets fever it means the vaccination is work-
ing. So we take this as a normal thing.
(IDI, mother, Tanzania)
However, in Gabon 21% (103/494) of mothers said they
knew other women who did not take their infants for vac-
cination because of the fever resulting from vaccination.
Less commonly reported side effects that were perceived
as serious, such as abscesses, did deter a few women from
returning to the clinic for the following vaccination. Three
percent (23/805) of mothers reported (what they per-
ceived to be) serious side effects (15/23 were from
Malawi). Mothers were sometimes concerned when their
child received a previously missed vaccination on top of
the scheduled one because they thought this might be too
strong, and this was also mentioned as a reason for not
returning to the clinic.
For many women in the implementation sites in Ghana
and Malawi, IPTi was simply an unnoticed addition to an
already routinized EPI. However, sometimes it was recog-
nized as something new, and the data from direct obser-
vation show that in Ghana some women with babies
falling outside the age range did come to the clinics
requesting 'the white drug'.
A majority of mothers (88% [709/805]) across the sites
reported the experience of IPTi as positive. Only in Malawi
did a noticeable number of mothers report their experi-
ence as neutral: 15% [29/194]). Some participants com-
pared the IPTi child with their siblings and perceived a
difference in the number of malaria episodes between
them. In the implementation sites, some mothers thought
that IPTi was meant to prevent the child from getting fever
after being vaccinated as they thought it was a pain killer.
Fathers in the trial sites in Tanzania and Kenya were more
likely to have heard about IPTi (all 48 interviewed fathers)
compared to those in the intervention sites in Malawi and
Ghana (44% [53/120]). In the trial sites fathers appear to
have played a key role in decision-making relating to IPTi
because the intervention involved participation in
research. The interviews with fathers reveal that women in
the non-trial sites tended not to inform their husbands as
much about IPTi.
In the study sites fathers are generally expected to provide
financial support for health care and are, because of this,
the ultimate decision makers regarding health care seek-
ing for children. However, they tend not to play a direct
role or be interested in day-to-day infant care (which
includes routine health seeking and treatment for minor
ailments). Most mothers (57% [455/805]) said that they
did need to consult their husbands whether to take their
children to the hospital, as there were costs involved, but
not for vaccination as it was free (Ghana 81%, Malawi
76%, Tanzania 45%, Kenya 24%). However, as soon as
health-related issues are perceived as non-routine (forMalaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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example, in the case of a clinical trial, or the introduction
of new drugs) then fathers do become more interested
and often intervene (negatively), based largely on igno-
rance of the facts and often stimulated by rumours, which
they play a part in spreading (based on in-depth inter-
views and focus groups with mothers, fathers and health
workers).
That is the issue of blood [stealing] that they [fathers] said
was the major cause of their kids getting more sick, and oth-
ers were saying that we were testing HIV/AIDS without
their consent while pretending that we are doing a malaria
study.
(IDI, health worker, Kenya)
Mother: I really longed to join [the IPTi trial] because the
child would be treated free of charge, but [the father of the
child] had some issues with this and I couldn't force him.
Interviewer: What was the issue?
Mother: It was the blood issue. People said that these chil-
dren were sickly and that they took a lot of blood from them.
Because he had heard these things, he didn't understand
even when I tried to explain. I even gave him that form
[information leaflet] and he read it. He also complained
that the drugs that were going to be used were powerful and
if the child's body got used to them, he would develop some
problems in the future if he completed the study.
(IDI, trial drop out mother, Kenya)
People were telling us not to take part in the project because
the children will get big heads [hydrocephalus] and they
will also get brain disorder. They claimed that white people
aimed to test their drugs on our children. Those who didn't
understand, they refused to take part in the project.
(FGD participant, Tanzania)
Interviewer: You said people mentioned mumiani [vam-
pires, blood-stealers], but generally, how did the commu-
nity respond to the project?
Opinion leader: Their response was good. Those who talk
about mumiani are the minority who do not understand,
but the majority accept the project.
(IDI, opinion leader, Tanzania)
When asked what they would do if their husbands refused
to allow them to take their children to the clinic not all
mothers responded; they could not imagine or had not
experienced such a situation. However, of those who
responded, 46% (239/518) would covertly or overtly defy
their husband; 11% (55/518) would obey their husband;
and other respondents reported that they would try to per-
suade their husband; they would postpone the question;
or were unsure. In explaining their defiance mothers
referred to the authority of the government or the respon-
sibility they were expected to assume for their baby's
health. The proportion of mothers who would defy or
obey their husband varied over the different sites. For
example, those who said they would obey ranged from
2% in Malawi to 15% in Ghana, and those who would
defy ranged from 30% in Malawi to 68% in Ghana.
The culture of the clinic
Health workers appeared to be generally motivated and
committed, and to encourage mothers to keep to the rou-
tine vaccination schedule and to comply with treatment
regimens. This emerged from interviews and focus groups
with mothers and community members, and was sup-
ported by follow-up interviews with health workers about
their motivation for choosing this occupation.
I had an interest and wanted to become a health worker. I
really liked seeing other workers giving out vaccines to
babies and helping them to get the best medication and to
grow up healthy. Thus I wanted to become one of the people
that was helping people and babies to grow up healthy and
strong.
(IDI, health worker, Malawi)
However, health workers also often complained that their
effort was not adequately rewarded, and some of those
involved in IPTi at the implementation sites felt that they
had been inadequately trained (62% [65/105]). Those
who had not received IPTi training felt resentful when
they were called upon to provide IPTi. Health workers
often reported being generally disappointed that patients
did not follow their advice.
Most mothers seemed to generally trust and respect health
workers, and in in-depth interviews frequently said they
had been assisted in a friendly way and they appeared to
do their best to conform to health workers' expectations
and show that they were good and responsible mothers.
Health workers were perceived as providing an essential
service.
...because the doctor or the nurse is in a way like Jesus who
has come to save us...
(IDI, mother, Gabon)
However, it was clear that when they perceived patients to
be non-compliant health workers became frustrated andMalaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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as a result sometimes publicly reprimanded or ridiculed
them. In the in-depth interviews 8% (20/242) of mothers
referred explicitly to insults or reprimands from health
workers.
The doctor on duty assesses if the child has been attending
EPI, if not, the mother of the child is reprimanded, some-
times they serve her last. But usually, they give a lecture to
other mothers about the consequences of not attending EPI,
and use the mother who was not attending as an example.
The idea is to warn other mothers that they will be embar-
rassed if they do not attend EPI.
(Observational field notes, Malawi)
Interviewer: What would have happened if you refused to
collect the white drug, and later you went to the clinic?
Mother: The nurses would insult me because it means I do
not want my child's welfare; I do not want to prevent dis-
ease.
(IDI, mother Ghana)
There is even the occasional report of physical punish-
ment:
One day I took the child to the hospital and when the nurse
examined the child she immediately gave me a slap and
rebuked me for waiting all this time when I could have
brought the child much earlier. She told me that if I had
waited another day the child would have died.
(FGD, mothers, Ghana)
In their interaction with clinic staff women tended to be
passive: they usually did not ask questions for fear that
this would be interpreted as a sign of ignorance and they
would be ridiculed by staff and laughed at by other
women, and they accepted this treatment without resist-
ing or questioning it.
It may be good or not...we just receive it because the doctors
say so.
(FGD, mothers, Malawi)
We don't know the difference between them [different
medications] but we take them because they give them to us
and tell us: 'take it' and we just do it.
(FGD, mothers, Ghana)
This passive acceptance was partly due to a local culture of
subservience (the underlying assumption being that one
should obey those higher up the social and educational
hierarchy) and partly due to fear of being refused help
when they might need it later (for example when they
come for delivery). Both of these factors were also impor-
tant in Mozambique and southern Tanzania. Once they
have missed one clinic session, mothers may then be less
inclined to return to the clinic out of fear that they will be
punished or ridiculed.
Sometimes there is no respect here, and this discourages
women, those who don't like to be insulted.
(IDI, mother, Gabon)
Also because of the way the nurses insult people who miss
clinic in the full view of other mothers, nobody wants to be
insulted by them so you will always try to go every time.
(FGD, mothers, Ghana)
If the culture inside the clinic was based on hierarchy and
authority, where the approval of health workers deter-
mined access to treatment, there was also a parallel culture
outside the clinic, in the waiting spaces where mothers
met each other and socialized. At all sites, vaccination
clinics were social events to which many women looked
forward as an opportunity to dress up and get away from
the daily routine of farm work and household chores. As
inside the clinic, this more informal social space also
formed a context for approval and disapproval – this time
from fellow mothers rather than health workers – and
while "good" mothers and well-dressed women received
approval, those who did not conform were ridiculed and
stigmatized (whether actually or in their own estimation).
This could also be a source of inequality for mothers who
did not have the means to keep up appearances, and
could lead to non-attendance.
For example, most of the young mothers interviewed in
Gabon (80% [184/231]) claimed that shame (honte)
related to having sick or malnourished infants, having too
many children, or being a young mother was a common
reason for avoiding routine clinic visits [18].
Facilitator: Are there some people that do not go to vacci-
nate their children?
FGD participant: For some it's lack of family plan-
ning...having a lot of kids with no child spacing...
Facilitator: So how would that stop someone from taking
their kid to get vaccinated?Malaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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Participant: The mother feels shy/ashamed, because she has
a child on her back and she is expecting another and can't
carry the third kid...
Several participants: Yes it's true...another child may be
crawling...another learning to sit...
Facilitator: She becomes shy because of who.do the doctors
laugh at her at the hospital?
Participant: Because of the other women too...she stays
away from them because she knows that what she did is
wrong...child bearing in such a manner.
(FGD, community members, Malawi)
Health worker: When we go for outreach [clinic] most
mothers don't come, so it's difficult to get them.
Interviewer: Why don't mothers come for outreach?
Health worker: It's because most of them prefer to go to the
main clinic to meet their colleagues, others too want to
come and exhibit their new dresses.
(IDI, volunteer health worker, Ghana)
Some of them look shabby...it could be that you have only
one piece of clothing that you use everywhere you go, while
others come to the clinic gorgeously dressed. So they [health
workers] discriminate against you by attending to them
first. These things discourage you.
(FGD, mothers, Ghana. Discussing why some women
do not take their children to the clinic)
These cultural factors were exacerbated by (perceived)
geographical and structural constraints, such as distance
to the clinics, poor infrastructure and long waiting times:
If I do not get to the clinic on time, they have finished talk-
ing to the women. It's because of the distance. When I get
up I have to clean, bathe the children and cook first, and all
that makes me late so I don't hear anything [of the health
education talk].
(IDI, mother, Ghana)
Drugs, regimens and delivery mode
The most important direct determinants of the acceptabil-
ity of an intervention are whether people perceive it as
doing what they think it should do, and whether the ben-
efits are perceived to outweigh the disadvantages. Side
effects (or rather perceived side effects) are an important
factor in determining acceptability. In this study 11% [85/
805]) of mothers (mostly in Kenya and Tanzania)
reported (perceived) side effects of IPTi (44 referred to
fever, 30 to vomiting, and 13 to diarrhoea). Only 14
mothers reported what they perceived to be serious side
effects from IPTi (all in Tanzania and Kenya), which
included diarrhoea (4), chest pain (2) convulsions (1),
sickle-cell anaemia (1) and rashes (1); five mothers did
not provide specific details. As in the case of vaccination
described above, the side effects of IPTi, when they were
reported, often tended to be interpreted as evidence of the
drug's potency.
Across the sites, the views of study participants on SP were
mixed. There were those who liked SP: they were familiar
with it, they had used it for years, they knew it was gener-
ally safe, in spite of rumours at some sites (derived from
newspaper reports) about it causing people's skin to peel
off.
SP is good; I have used it, and my child has used it, and the
same applies to my wife when she was pregnant, so it is
good.
(SSI, father, Tanzania)
In Gabon, 71% (85/119) of trial participants said that the
drugs given as part of the trial were "good" – 56% (67/
199) "knew" that their infants had received SP.
On the other hand, the fact that it has been replaced as
first line treatment suggested to some mothers that it was
no longer effective, and the newer drugs introduced to
replace SP were generally perceived as stronger and more
effective. This was especially true in the trial sites where
drugs that were being researched were seen as more pow-
erful than those currently being prescribed.
Mother 1: For me Fansidar [SP] never works. I have always
taken quinine. It works better. It is the real medicine for
malaria; and aspirin and Panadol.
Mother 2: For me too, Fansidar never works for me. I think
that quinine is the best. Fansidar does not do anything. It
never makes anyone better. Everyone complains about Fan-
sidar nowadays. I think it stopped working. I don't know; is
it still the same people who make it? It is not like it used to
be.
(FGD, mothers, Malawi)
The other side of this is that the newer drugs were often
perceived as being too strong for people who have a
weaker constitution, such as infants and the elderly. The
fact, mentioned above, that in the trial settings infants areMalaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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often reported to have vomited after receiving the trial
drugs, was sometimes interpreted as evidence of this.
Both mothers and health workers generally did not like
the crushing of tablets (33% [57/174] of health workers
said it was "difficult") and their administration to the
child using cups and spoons (46% [53/116] of health
workers from the implementation sites in Ghana and
Malawi described it as impractical). Mothers were mainly
concerned about hygiene, but the practical difficulty of
getting infants to swallow the drug and the fact that they
often spat most of it out again also played a role. Obser-
vations in the clinics made it clear that infants often spat
out a substantial amount of the drug. There were also con-
cerns in the implementation sites about the administra-
tion of water to infants and how this might contradict
advice on exclusive breastfeeding.
I really do not like the way that the Fansidar [SP] is given.
We all have to use the same cups. They don't even rinse
them out properly, they just throw them into the water and
take them out, and that's it...The problem is that we can't
complain. If you did, they would turn against you and ask
you who you think you are, complaining when no one else
is.
(IDI, mother, Malawi)
In Kenya, both mothers and health workers reported (in
interviews and FGDs) that the introduction of a syringe to
squirt the dissolved drug into the infant's mouth was a big
improvement. However, some mothers did not like the
look of the syringe, which made it seem like their child
was being injected in the mouth. There was general agree-
ment among both mothers and health staff across the sites
that an infant formulation would be necessary to ensure
acceptance in the long run.
In Tanzania, the trial included an aspect of home admin-
istration. The first of three doses was given at the clinic
and the mother administered the remaining doses at
home on the following two days. Monitors (12/13) who
followed the mothers up to check they had given the sub-
sequent doses claimed that some women did not comply
and that they forgot to administer the drugs or kept the
tablets for subsequent use.
In Kenya, the trial also included home administration.
However there the compliance monitors travelled to the
mothers' homes with the drugs and supervised their
administration (waiting 30 minutes to ensure that the
infant did not vomit). During interviews Kenyan compli-
ance monitors reported being sceptical about mothers'
ability to administer drugs without supervision and 4/6 of
them referred to cases of non-compliance with trial proce-
dures.
In Tanzania, the monitors had varied opinions about
mothers' ability to administer drugs correctly without
supervision. Although some were pessimistic, they sug-
gested that the trial context may negatively influence
mothers' compliance (due to suspicion about the drugs)
and that adherence might be greater in a non-research set-
ting.
Various other factors relating more or less directly to the
mode of delivery also impeded the implementation of
IPTi. So, for example, in some of the clinics gender roles
interfered:
Obviously I have trouble [delivering IPTi] because, being a
man, I can't just take the cups and wash them. I have to
leave them because that is something that the women are
supposed to do. That means that whoever comes on that day
for the IPTi will not receive it.
(IDI, health worker, Malawi)
While such explicit statements were not common, they
did express much broader underlying issues that
impinged on the quality of care in these settings.
In the trial sites, the free medical attention provided to
infants acted to counter-balance the scattered reports of
side effects, beliefs about the drugs being too powerful,
and the rumours about blood stealing and covert HIV-
testing. The free medical attention was a commonly cited
motivating factor for trial participation, particularly in
Kenya.
In Malawi, the fact that the measles vaccine came in preset
quantities meant that if the number of babies needing vac-
cination did not match the amount of vaccine in the bot-
tle, the remaining women were sent home without their
infant having received either a measles vaccination or IPTi
because the health workers were reluctant to waste medi-
cine by opening a new bottle.
In the implementation study sites, particularly in Ghana,
there were reports of busy health workers handing the dis-
solved SP tablets to the mothers and permitting them to
administer the drug to their infants. This was also
observed in the clinics in Malawi (though when staff were
questioned they denied this). This led to some cases of
mothers not administering all the drug solution.
Scattered reports also emerged from Malawi and Ghana of
health workers providing mothers with the SP tablets and
instruction on how to administer the drug at home. ThisMalaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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also occurs in the implementation site in southern Tanza-
nia [11]. In Ghana, the health workers apparently allowed
more educated mothers to do this, as they were under
pressure for resources, particularly the cups used to dis-
solve the SP tablets.
IPTi-EPI interactions
There is little evidence in any of the study sites that IPTi
per se had a negative impact on attitudes to EPI or that it
had any effect on EPI adherence. Only 2% (6/805) of
mothers said that IPTi had discouraged them from EPI
attendance. Of the fathers 6% (10/168) said that IPTi
might be a reason for them to discourage EPI clinic attend-
ance. However, this was related to research procedures, in
particular blood taking. Because EPI was generally valued
positively, IPTi benefited from being associated with it.
Mothers generally did not think that having received IPTi
meant that their child would no longer get malaria. This
was not because they were aware of the limited protection
actually offered by IPTi, or the fact that at some of the sites
the drugs were being tested in efficacy trials, but rather
because they generally viewed all prevention practices,
whether traditional or biomedical, as partial.
The disease won't hit him as much as when he would have
never taken any medication.
(IDI, mother, Gabon)
This view of prevention resonated with traditional preven-
tive practices for infants that were common across all the
sites (see below). These findings are the same as those
from Mozambique and southern Tanzania.
However, across the sites a minority of mothers (16%
[126/805]) did think that their child would no longer get
malaria as a result of having received IPTi. There were dif-
ferences between the sites in this regard, with 27% (56/
206) of mothers in Ghana thinking that their child would
be completely protected against malaria, compared to
only 3% (5/194) of mothers in Malawi. In Tanzania and
Kenya the proportions were 15% (31/208) and 17% (34/
197) respectively.
Some mothers (11% [91/805]) reported seeking less treat-
ment for febrile illness in their infants while they were
receiving IPTi compared to prior to IPTi. This varies from
2% in Malawi to 17% in Kenya and Tanzania). There is
evidence that some of this reduction was due to exagger-
ated assumptions by mothers about the extent of protec-
tion offered by IPTi. However, the reduction is potentially
due to less (perceived) illness after IPTi. Two percent (15/
805) (all in Ghana) of mothers reported that they would
be less likely to seek treatment or would delay seeking
treatment because of IPTi.
In Ghana and Malawi a majority of mothers reported no
change in bed net use during IPTi: 83% (170/206) and
87% (77/106) respectively. In Kenya and Tanzania moth-
ers reported an increase in bed net use since IPTi: 25%
(47/192) and 22% (23/106) respectively of mothers
reported using bed nets more than prior to IPTi. This was
largely due the fact that the two trials distributed nets to
participants. For the 4% (26/612) of participants across
these four sites who reported using bed nets less than
before IPTi, the main reason was the net being damaged,
followed by lack of mosquitoes. Only two participants
directly related reduced net use to IPTi. In the Gabon
study site there was 80% bed net use, of which 5% were
insecticide-treated. However, there are no data on changes
in use due to the trial.
Discussion
The studies reported in this paper were part of a broad
programme of research aimed at exploring the reception
of IPTi in a wide range of settings using different drugs and
regimens. In particular, the studies aimed to understand
(potential) facilitating factors and barriers to longer-term
implementation. While the investigation of an interven-
tion in the context of a clinical trial is not ideal, it is often
the only way of collecting acceptability data early enough
to be able to make recommendations for improving
access and long-term adherence. This project had the
advantage of also being able to collect data from two
implementation settings. These data, together with the
data relating to anti-malarial drugs other than SP and to
different regimens, combined with the results from the
two earlier studies – one of which was also an implemen-
tation study, have generated a broad and generalizable set
of data relating to the acceptability of IPTi across a broad
range of settings.
A number of key factors have emerged relating to the
acceptability of IPTi. They mainly relate to various aspects
of local culture (both inside and outside the clinic), to the
fact that IPTi is delivered through EPI, and to the nature of
the different drugs and regimens (and how these are inter-
preted). There is a great deal of similarity regarding all
these issues across the different sites.
In all the study communities, there was a general concern
about infant health. Mothers were generally motivated to
comply with prevention practices, whether traditional or
biomedical, regardless of whether they fully understood
them. Because non-compliance could be interpreted as
neglect, there was also strong social pressure on mothers
to comply and be seen as a "good mother". Traditional
prevention practices and the belief that these are only par-Malaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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tially effective were common at all sites, and the resonance
between such traditional practices and EPI/IPTi, together
with the general concern about infant health, formed a
propitious context for the acceptance and routinization of
both EPI and IPTi. These findings are similar to those from
the earlier studies of IPTi reception in Mozambique and
southern Tanzania [11,12].
Beyond local health culture, this acceptance was also
related to a hierarchical culture of subservience and
respect for authority that is particularly strong in the clinic
setting where it is reinforced by dependence. As a result,
women often said that they attended the clinic because
they had been told to, or because they had to, or because
it was "the law". In this context, women seemed to accept
intimidation, and even occasionally overt bullying, with-
out resisting or questioning. However, this sometimes
had the opposite effect when fear of intimidation led to
women avoiding the clinic. So although the culture of
subservience works in both directions, its main influence
is toward adherence. The relationship between mothers
and health workers tends to be ambivalent: health work-
ers have power and authority and women fear them, but
women also respect and trust them, and this in turn con-
tributes positively to clinic attendance and adherence.
Their relationship is also reciprocal, and adherence can be
seen as part of an exchange relationship between patients
and health workers, with approval and assurance of future
assistance being exchanged for adherence. The dynamics
of this process are somewhat different in research settings
compared to routine intervention settings. In the former
the stakes are higher: there are more perceived risks and
uncertainties (potentially dangerous drugs, blood steal-
ing, being a research "guinea pig"), but the benefits are
also potentially greater (more effective drugs, free and
privileged access to health care) [19].
The social dynamics between health workers and women
played an important role in the acceptance of and adher-
ence to IPTi, but so too did the social dynamics amongst
the women themselves. Vaccination clinics were also
social events to which many women saw as an opportu-
nity to dress up and get away from the daily routine of
farm work and household chores, and socialize. This
aspect attracted women to the clinic and thus contributed
to attendance and adherence, but, as with the relationship
with the health workers, there was an ambivalent aspect,
and disapproval could lead to non-adherence. This is par-
ticularly worrying in Gabon, where not only being poorly
dressed, but also having an unhealthy child could be a
cause of peer disapproval and clinic avoidance.
Fathers tend not to play a major role in routine infant care
(including health seeking and treatment), which is seen as
the mother's job. However, when men perceive health-
related issues as non-routine (for example in the case of
research or the introduction of new drugs), they become
more interested and may intervene (negatively) by forbid-
ding participation or demanding withdrawal. This
response seems to be based largely on lack of knowledge
about the intervention or misinterpretations based on
rumour. This was very clear in the study in Mozambique,
in which almost all the women who refused to enrol in, or
who defaulted from, the IPTi trial did so because of pres-
sure from husbands who had heard rumours that the
researchers stole blood [12]. This suggests that sensitiza-
tion about new interventions or research should be deliv-
ered more broadly and specifically include men, even if
the intervention or research focuses on women or chil-
dren.
EPI is generally well accepted and has become routinized
because it is perceived as beneficial and because it fits in
to local health culture. In this context the addition of IPTi
in the form of a single dose of a familiar drug tends to be
accepted more-or-less without question (unless negative
attention is focused on the intervention, for example in
the form of rumours about skin peeling off or blood steal-
ing). Moreover, women were already familiar with IPTp,
which involves the use of the same drug for the same pur-
pose (partial protection against malaria through the
administration of an anti-malarial).
One of the main determinants of acceptability is whether
people perceive the intervention as doing what they think
it is supposed to do, and whether the benefits are per-
ceived to outweigh the disadvantages. In the case of IPTi,
much of this relates to the perceived characteristics of the
anti-malarial drugs. As with the other factors discussed
above, most of the factors relating to the characteristics of
the drugs or the way they were administered had both
facilitating and impeding potential. People balance the
pros and cons of the medication and are willing to tolerate
perceived disadvantages as long as the benefits are
thought to be worthwhile. So, for example, mothers were
prepared to accept some fever and local swelling in order
to reap the health benefits of vaccination. Similarly, in the
research sites in Kenya and Tanzania they appeared to be
willing to accept the vomiting and fever that were reported
to follow IPTi as a price worth paying for a more effective
drug and less malaria (just as they were willing to take the
risk of blood stealing in order to benefit from the free
health care provided by the trial clinics). Because these
influences are often impossible to separate, especially in
the trial settings, it is difficult to be clear about what pre-
cisely motivates mothers to attend clinic and adhere to
treatment, and this makes it difficult to assess how they
would respond in a more routine implementation setting.
Much will depend on how patients link specific character-
istics to particular drugs. For example, in Tanzania the tri-Malaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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alists linked the vomiting reported by mothers to
mefloquine and chlorproguanil-dapsone (and not to SP
and placebo). As mothers did not know which drug their
child was on, they could only link it to the "more power-
ful" drugs. In an implementation setting, a clear perceived
link between a particular drug and an unacceptable side
effect might lead to widespread non-adherence, especially
if other drugs that are perceived to be equally effective are
available.
Many study participants liked SP: they were familiar with
it, they had used it for years, and they knew it was gener-
ally safe, in spite of rumours at some sites about it causing
people's skin to peel off. There were those who were con-
vinced that it was the best drug for them personally. But
there was also ambivalence due to the fact that on the one
hand it has been replaced as first-line treatment, suggest-
ing that it is no longer effective, and on the other it is
being promoted for IPTp and IPTi. There were also those
who did not like SP because they perceived it as ineffec-
tive. This may be because of resistance, but it could also be
related to the fact that SP has a relatively slow onset of
action and no antipyretic effect. It is therefore possible
that, although some people are still satisfied with SP (and
it is still generally acceptable for IPTp and IPTi), this may
change as people become aware of more powerful drugs
and start to expect them for both treatment and preven-
tion. It is also possible that this interpretation will affect
perceptions of existing first-line treatment in settings in
which other drugs are being tested, because participants
tend to assume that the trial drugs are more effective than
those in routine use, and that new drugs are being tested
because existing ones are becoming less effective.
It is clear from the data that the crushing of tablets and
their administration to the child using cups and spoons is
not popular: mothers thought it was unhygienic, health
workers claimed it was time-consuming and observation
confirmed that it was often unpractical. There was general
agreement among both mothers and health staff that eas-
ily deliverable infant formulation would be necessary for
longer-term acceptability. However, this does need to be
interpreted in the context of the balancing of pros and
cons mentioned above: women are willing to tolerate the
messy administration of the drug (just as they are willing
to accept some side effects) if they perceive it as increasing
the health of their infant. In the case of health workers,
acceptance may be achieved through the gradual routini-
zation of IPTi into the EPI process. There are probably lim-
its to this, however, and the continued addition of new
interventions to EPI would probably need to be accompa-
nied by some increase in (perceived) rewards.
The number of doses and the complexity of the regimen
are also key factors in acceptability and adherence. It
seems intuitively obvious that a single dose of a familiar
drug administered under supervision in the clinic will
achieve higher adherence than a multi-dose regimen of a
new drug administered at home, and this is what the evi-
dence suggests. This is strengthened by various other fac-
tors.
First, people may be less inclined to take three tablets if
they can achieve what they want with only one – they then
have some to spare for another occasion. Also, the fact
that the new drugs being tested in the trials in Tanzania
and Kenya were seen as more powerful supports the logic
of saving some for later (why give three doses of a strong
drug to achieve the same as you would achieve with a sin-
gle dose of a weaker drug?). Multiple doses given in the
clinic may be more feasible than multiple doses at home,
but getting busy women to come for follow-up visits is
likely to be a challenge.
Second, the mere fact of multiple doses taken at home
increases the risk of forgetting, losing tablets, sharing with
friends, etc. In the case of the Tanzania and Kenya trials,
adherence was built into the trial design with compliance
monitors and home visits (though the trials were fairly
different in this regard, with monitors just assessing com-
pliance in Tanzania, while Kenya staff supervised the
actual taking of the drugs at home). Health workers and
monitors agreed that that multiple doses at home would
not work, and some mothers admitted that it would be
challenging and that they would be inclined to forget or
save doses for later. This could not be observed first hand
in the trial sites, as the acceptability studies started at the
end of implementation, but there is some evidence of this
behaviour from the implementation study in southern
Tanzania, where busy clinic staff sometimes gave mothers
the single dose of SP to take at home, and home visits by
the researchers revealed that the drug had not been
administered [11,20].
However, there are reasons not to be entirely pessimistic
about this. First, some women were conscientious and did
adhere to medication, for example some of the women
who were given SP for home administration did so prop-
erly; they understood the importance of taking the drug as
prescribed and it is perhaps patronising to assume that
uneducated rural women are completely incapable of
understanding the importance of adherence [20]. Moreo-
ver, health workers in some of these settings do tend to be
pessimistic about the ability of rural women to under-
stand and comply with treatment [21]. Second, some
health workers were nonetheless optimistic that women
could be adherent to multiple doses if they were given
proper information and the right degree of support. The
data suggest that too much support (as in the intensive
follow-up during the trials) perhaps leads to passivity andMalaria Journal 2009, 8:191 http://www.malariajournal.com/content/8/1/191
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over-reliance on reminders and that in the longer term a
more empowering approach might work better.
One of the major concerns relating to the introduction of
IPTi into the EPI scheme was that if communities viewed
IPTi negatively then this might lead to reduced EPI clinic
attendance. There is little evidence, either from the data
described in this paper or the studies in southern Tanzania
and Mozambique, that IPTi in itself had any negative
impact on attitudes to EPI or that it had any effect on EPI
adherence. The few cases in which participants claimed
that IPTi was a reason for avoiding EPI were largely related
to the research process and the taking of blood in particu-
lar, rather than to IPTi per se.
Another concern was that the concurrent delivery of IPTi
and immunization might lead people to perceive IPTi as
immunization against malaria and as a result they might
stop using other preventive measures such as bed nets.
Mothers did not generally think that having received IPTi
meant that their child would no longer get malaria
because they tended to view all prevention practices as
partial – attenuating rather than completely preventing
disease. Moreover, even if women did think that their
child was now immune to malaria, this would not neces-
sarily mean that they would fail to seek treatment if the
child became febrile because, due to the general difficulty
in distinguishing between malaria and non-malarial fever
(as shown by the fact that there is only a single term in
most languages), mothers would be likely to seek treat-
ment anyway.
Conclusion
This paper has reported on a comprehensive study of the
acceptability and reception IPTi in five settings in Africa. It
also refers to already published studies in two additional
settings, carried out by the same group. This programme
of anthropological research has revealed a great deal of
similarity across very different sites and settings and there-
fore allows some generalization relating to the implemen-
tation of IPTi across Africa. First, IPTi delivered through
EPI fits well with local health cultures and appears to
become easily routinized. It resonates with traditional
practices (which should be evaluated for possible harmful
effects), which appear to be widespread. As a result, delib-
erately fitting interventions more closely to local culture
(by involving traditional healers or making use of the
social culture of the clinic) could improve adherence. Sec-
ond, there is little evidence that IPTi has any negative
impact on attitudes to EPI or EPI adherence. There is also
little evidence that the concurrent delivery of IPTi and
immunization has led to people perceiving IPTi as immu-
nization and changing existing health-seeking behaviour
detrimentally. Third, local understanding of new drugs
and regimens (and existing ones) is patchy and often inac-
curate. Information provision should focus on issues that
participants consider relevant (efficacy of different drugs,
reasons for new drugs and regimens, and details of side
effects and their meaning) and be broadened to include
fathers. Informal information channels (such as those
through which rumours spread) should be investigated
further as a potential means of countering misinforma-
tion and reaching the wider community. Fourth, it is
important that an infant formulation is developed, and
this should ideally be a single dose, administered in the
clinic as part of EPI.
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